Literature DB >> 1503353

Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management.

R O Bonow1, J E Udelson.   

Abstract

OBJECTIVE: To define the mechanisms underlying left ventricular diastolic dysfunction in patients with congestive heart failure and normal systolic function and to identify the patients at risk for this syndrome. STUDY SELECTION: Studies were selected that describe the clinical observations of congestive heart failure with normal systolic function and that provide experimental and clinical insights into the mechanisms responsible for ventricular diastolic dysfunction. DATA SYNTHESIS: Recent studies indicate that a large number of patients (up to 40% in some series) presenting with congestive heart failure have preserved left ventricular systolic function. The factors contributing to altered left ventricular diastolic function include fibrosis, hypertrophy, ischemia, and increased afterload. The latter three factors, alone or in combination, predispose to impaired left ventricular relaxation, an active energy-requiring process. Thus, decreased left ventricular diastolic distensibility (increased diastolic pressure at any level of diastolic volume) may arise not only from altered passive elastic properties stemming from fibrosis or increased muscle mass but also from derangements in the dynamics of ventricular relaxation.
RESULTS: In patients with essential hypertension, all four of the above mechanisms may be operative. Considering the prevalence of hypertension in the general population, hypertension appears to be an important underlying factor in many patients with heart failure on the basis of diastolic mechanisms. In the patient presenting with dyspnea and elevated filling pressures, but with a nondilated, normally contracting ventricle, treatment with standard heart failure medications (such as digitalis, diuretics, and vasodilators) is often ineffective and may be deleterious. Such patients may respond more favorably to beta-blockers and calcium-channel blockers.
CONCLUSIONS: Diastolic dysfunction should be considered in the patient presenting with heart failure symptoms but with normal systolic function, particularly in hypertensive patients with left ventricular hypertrophy.

Entities:  

Mesh:

Year:  1992        PMID: 1503353     DOI: 10.7326/0003-4819-117-6-502

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  54 in total

Review 1.  Pathophysiology of heart failure: a look at the future.

Authors:  R M Delgado; J T Willerson
Journal:  Tex Heart Inst J       Date:  1999

Review 2.  Are angiotensin-converting enzyme inhibitors and beta-blockers making an impact on the epidemiology of heart failure?

Authors:  Kirkwood F Adams
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

Review 3.  Care of patients with failing hearts: evidence for failures in clinical practice and health services research.

Authors:  C M Ashton
Journal:  J Gen Intern Med       Date:  1999-02       Impact factor: 5.128

4.  Classification of heart failure in population based research: an assessment of six heart failure scores.

Authors:  A Mosterd; J W Deckers; A W Hoes; A Nederpel; A Smeets; D T Linker; D E Grobbee
Journal:  Eur J Epidemiol       Date:  1997-07       Impact factor: 8.082

Review 5.  Echocardiographic assessment of left ventricular function.

Authors:  Mario J Garcia
Journal:  J Nucl Cardiol       Date:  2006 Mar-Apr       Impact factor: 5.952

6.  A Predictive Study of the Dynamic Development of the P-Wave Terminal Force in Lead V1 in the Electrocardiogram in Relation to Long-Term Prognosis in Non-ST-Segment Elevation Acute Coronary Syndrome Patients during Hospitalization.

Authors:  Qiao Li; Li-Dan Gu; Chen Zhang; Wei Liu; Yong Peng; Hua Chai; Yuan-Ning Xu; Jia-Fu Wei; Mao Chen; De-Jia Huang
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-02-09       Impact factor: 1.468

7.  Correlates of major complications and mortality in patients presenting to the emergency department with chest pain and more than bibasilar rales.

Authors:  M H Chin; E F Cook; T H Lee; L Goldman
Journal:  J Gen Intern Med       Date:  1994-12       Impact factor: 5.128

Review 8.  Antihypertensive drugs and the heart.

Authors:  Joseph A Diamond; Robert A Phillips
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

Review 9.  Diastolic function in hypertension.

Authors:  R A Phillips; J A Diamond
Journal:  Curr Cardiol Rep       Date:  2001-11       Impact factor: 2.931

10.  Temporal changes in myocardial collagen, matrix metalloproteinases, and their tissue inhibitors in the left ventricular myocardium in experimental chronic mitral regurgitation in rodents.

Authors:  Daniella Corporan; Daisuke Onohara; Roberto Hernandez-Merlo; Alicja Sielicka; Muralidhar Padala
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-08-24       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.